nodes	percent_of_prediction	percent_of_DWPC	metapath
Colestipol—Flatulence—Cisplatin—urinary bladder cancer	0.00349	0.00349	CcSEcCtD
Colestipol—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Colestipol—Cardiac disorder—Etoposide—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Colestipol—Muscle spasms—Cisplatin—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Colestipol—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Colestipol—Somnolence—Thiotepa—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Colestipol—Dyspepsia—Thiotepa—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Colestipol—Arthralgia—Gemcitabine—urinary bladder cancer	0.00323	0.00323	CcSEcCtD
Colestipol—Chest pain—Gemcitabine—urinary bladder cancer	0.00323	0.00323	CcSEcCtD
Colestipol—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00321	0.00321	CcSEcCtD
Colestipol—Decreased appetite—Thiotepa—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Colestipol—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Colestipol—Chest pain—Fluorouracil—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Colestipol—Fatigue—Thiotepa—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Colestipol—Constipation—Thiotepa—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Colestipol—Pain—Thiotepa—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Colestipol—Back pain—Etoposide—urinary bladder cancer	0.00314	0.00314	CcSEcCtD
Colestipol—Muscle spasms—Etoposide—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Colestipol—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Colestipol—Pain in extremity—Epirubicin—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Colestipol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Colestipol—Skin disorder—Gemcitabine—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Colestipol—Anxiety—Cisplatin—urinary bladder cancer	0.003	0.003	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Colestipol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Colestipol—Tachycardia—Fluorouracil—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Colestipol—Migraine—Epirubicin—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Colestipol—Anorexia—Gemcitabine—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Colestipol—Urticaria—Thiotepa—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Colestipol—Vertigo—Etoposide—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Colestipol—Abdominal pain—Thiotepa—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Colestipol—Anorexia—Fluorouracil—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Colestipol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Colestipol—Tachycardia—Cisplatin—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Colestipol—Skin disorder—Cisplatin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Colestipol—Insomnia—Gemcitabine—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Colestipol—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Colestipol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Colestipol—Chest pain—Etoposide—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Colestipol—Insomnia—Fluorouracil—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Colestipol—Somnolence—Gemcitabine—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Colestipol—Anorexia—Cisplatin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Colestipol—Migraine—Doxorubicin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Colestipol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Colestipol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Colestipol—Somnolence—Fluorouracil—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Colestipol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Colestipol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Colestipol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Colestipol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Colestipol—Fatigue—Gemcitabine—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Colestipol—Pain—Gemcitabine—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Colestipol—Constipation—Gemcitabine—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Colestipol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Colestipol—Asthenia—Thiotepa—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Colestipol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Colestipol—Abdominal distension—Epirubicin—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Colestipol—Dysphagia—Epirubicin—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Colestipol—Pain—Fluorouracil—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Colestipol—Tachycardia—Etoposide—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Colestipol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Colestipol—Skin disorder—Etoposide—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Colestipol—Angina pectoris—Epirubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Colestipol—Anorexia—Etoposide—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Colestipol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Colestipol—Decreased appetite—Cisplatin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Colestipol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Colestipol—Drowsiness—Methotrexate—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Colestipol—Pain—Cisplatin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Colestipol—Dizziness—Thiotepa—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Colestipol—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Colestipol—Urticaria—Fluorouracil—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Colestipol—Dysphagia—Doxorubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Colestipol—Dyspnoea—Etoposide—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Colestipol—Somnolence—Etoposide—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Colestipol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Colestipol—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Colestipol—Vomiting—Thiotepa—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Colestipol—Drowsiness—Epirubicin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Colestipol—Rash—Thiotepa—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Colestipol—Dermatitis—Thiotepa—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Colestipol—Headache—Thiotepa—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Colestipol—Decreased appetite—Etoposide—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Colestipol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Colestipol—Fatigue—Etoposide—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Colestipol—Pain—Etoposide—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Colestipol—Constipation—Etoposide—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Colestipol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Colestipol—Asthenia—Gemcitabine—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Colestipol—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Colestipol—Nausea—Thiotepa—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Colestipol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Colestipol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Colestipol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Colestipol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Colestipol—Urticaria—Etoposide—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Colestipol—Abdominal pain—Etoposide—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Colestipol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Colestipol—Asthenia—Cisplatin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Colestipol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Colestipol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Colestipol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Colestipol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Colestipol—Dizziness—Fluorouracil—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Colestipol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Colestipol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Colestipol—Vomiting—Gemcitabine—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Colestipol—Mental disorder—Methotrexate—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Colestipol—Rash—Gemcitabine—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Colestipol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Colestipol—Hypersensitivity—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Colestipol—Malnutrition—Methotrexate—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Colestipol—Headache—Gemcitabine—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Colestipol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Colestipol—Vomiting—Fluorouracil—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Colestipol—Rash—Fluorouracil—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Colestipol—Dermatitis—Fluorouracil—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Colestipol—Headache—Fluorouracil—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Colestipol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Colestipol—Asthenia—Etoposide—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Colestipol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Colestipol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Colestipol—Back pain—Methotrexate—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Colestipol—Nausea—Gemcitabine—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Colestipol—Vomiting—Cisplatin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Colestipol—Mental disorder—Epirubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Colestipol—Rash—Cisplatin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Colestipol—Dermatitis—Cisplatin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Colestipol—Malnutrition—Epirubicin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Colestipol—Diarrhoea—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Colestipol—Nausea—Fluorouracil—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Colestipol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Colestipol—Flatulence—Epirubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Colestipol—Back pain—Epirubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Colestipol—Dizziness—Etoposide—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Colestipol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Colestipol—Vertigo—Methotrexate—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Colestipol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Colestipol—Nausea—Cisplatin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Colestipol—Mental disorder—Doxorubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Colestipol—Vomiting—Etoposide—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colestipol—Malnutrition—Doxorubicin—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colestipol—Rash—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Colestipol—Dermatitis—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Colestipol—Headache—Etoposide—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Colestipol—Flatulence—Doxorubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Colestipol—Arthralgia—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Colestipol—Chest pain—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Colestipol—Vertigo—Epirubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Colestipol—Back pain—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Colestipol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Colestipol—Nausea—Etoposide—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Colestipol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Colestipol—Chest pain—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Colestipol—Arthralgia—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Colestipol—Anxiety—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Colestipol—Skin disorder—Methotrexate—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Colestipol—Vertigo—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Colestipol—Anorexia—Methotrexate—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Colestipol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Colestipol—Tachycardia—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Colestipol—Skin disorder—Epirubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Colestipol—Insomnia—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colestipol—Chest pain—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colestipol—Arthralgia—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colestipol—Anxiety—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Colestipol—Anorexia—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Colestipol—Dyspnoea—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Colestipol—Somnolence—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Colestipol—Dyspepsia—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Colestipol—Decreased appetite—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Colestipol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Colestipol—Fatigue—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Colestipol—Pain—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Colestipol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Colestipol—Insomnia—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Colestipol—Tachycardia—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Colestipol—Skin disorder—Doxorubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Colestipol—Dyspnoea—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Colestipol—Somnolence—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Colestipol—Anorexia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Colestipol—Dyspepsia—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Colestipol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Colestipol—Decreased appetite—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Colestipol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Colestipol—Fatigue—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Colestipol—Pain—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Colestipol—Constipation—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Colestipol—Urticaria—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Colestipol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Colestipol—Insomnia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Colestipol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Colestipol—Somnolence—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Colestipol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Colestipol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Colestipol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Colestipol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Colestipol—Fatigue—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Colestipol—Urticaria—Epirubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Colestipol—Pain—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Colestipol—Constipation—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Colestipol—Abdominal pain—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Colestipol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Colestipol—Asthenia—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Colestipol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Colestipol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Colestipol—Urticaria—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Colestipol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Colestipol—Diarrhoea—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Colestipol—Asthenia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Colestipol—Dizziness—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Colestipol—Diarrhoea—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Colestipol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Colestipol—Vomiting—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Colestipol—Rash—Methotrexate—urinary bladder cancer	0.000999	0.000999	CcSEcCtD
Colestipol—Dermatitis—Methotrexate—urinary bladder cancer	0.000998	0.000998	CcSEcCtD
Colestipol—Headache—Methotrexate—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Colestipol—Asthenia—Doxorubicin—urinary bladder cancer	0.000984	0.000984	CcSEcCtD
Colestipol—Dizziness—Epirubicin—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Colestipol—Vomiting—Epirubicin—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Colestipol—Nausea—Methotrexate—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Colestipol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000939	0.000939	CcSEcCtD
Colestipol—Rash—Epirubicin—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Colestipol—Dermatitis—Epirubicin—urinary bladder cancer	0.000934	0.000934	CcSEcCtD
Colestipol—Headache—Epirubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Colestipol—Dizziness—Doxorubicin—urinary bladder cancer	0.000907	0.000907	CcSEcCtD
Colestipol—Nausea—Epirubicin—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Colestipol—Vomiting—Doxorubicin—urinary bladder cancer	0.000872	0.000872	CcSEcCtD
Colestipol—Rash—Doxorubicin—urinary bladder cancer	0.000865	0.000865	CcSEcCtD
Colestipol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000864	0.000864	CcSEcCtD
Colestipol—Headache—Doxorubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Colestipol—Nausea—Doxorubicin—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
